Assisted Reproductive Technology Market Report

Assisted Reproductive Technology Market Report, By Type (In-Vitro Fertilization (IVF), Artificial Insemination and Surrogacy), Product (Instruments, Reagents and Media and Accessories and Disposables), End Users and Geography – Global Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : 11474 | Publish Date : Upcoming | Industry : Healthcare | Geography : Global


MARKET OVERVIEW- GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET

Assisted reproductive technologies such as in vitro fertilization (IVF), artificial insemination (AI-IUI) and frozen embryo replacement are used in fertility clinics and surgical centers for infertility treatment. The growth of the global market for assisted reproductive technologies is mainly driven by an increase in the prevalence of infertility; increased funding from private and public organizations for infertility services; raising awareness of infertility treatment and surrogacy; and the advancement of technology in assisted reproductive technology. People's busy lifestyles and rising stress levels have led to an increase in infertility rates in many developed and developing countries around the world. Also, a tremendous rise in healthcare spending along with a huge technological development with respect to reproductive healthcare are key factors which are anticipated to provide ample of new growth opportunities for the market over the estimated time period. 

MARKET DRIVERS 

Factors such as increased infertility cases, improved success rate of assisted reproductive technology, and increased disposable income in developing countries are expected to drive the industry's growth over the forecast period. According to statistics from the World Health Organization 2020, about 186 million people around the world have problems related to infertility. The increasing prevalence of infertility can be attributed to several factors, including due to sexually transmitted diseases (STDs), increasing numbers of cigarette smokers, cases of obesity, endometriosis, polycystic ovary syndrome (PCOS), primary ovarian failure (POC), and others.

The ncreaseing adoption of assisted reproductive technology in society through the application of more advanced technologies, such as pre-implantation genetic testing (PGT), endometrial receptivity analysis tests (ERA), activated magnetic cell sorting (MACS), and time-lapse imaging of embryos, is expected to guide the application of ART procedures. For example, according to the Centers for Disease Control and Prevention (CDC) Fertility Clinic Success Rates 2019 report, approximately 330,773 ART procedures were performed at 448 fertility clinics in the United States, equivalent to 77,998 live births and 83,946 live births. Additionally, the increasing awareness of the causes and treatment of infertility is expected to drive the growth of the market over the estimated time period.

MARKET OPPORTUNITIES

The market is expected to have new opportunities with the technological advancements and ongoing R&D activities involved in reproductive healthcare. This is expected to provide ample new growth opportunities for the market during the forecast period. Also, several organizations, such as the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology (SART), are working together to raise awareness about infertility treatment options, and this factor is expected to provide increasing new growth opportunities for the market over the forecast period. 

MARKET RESTRAINTS

Assisted reproductive technology is associated with potential risks to the mother and fetus. Perinatal risks that may be associated with assisted reproductive technology (ART) and ovulation induction include multifetal pregnancies, prematurity, low birth weight, reduced gestational age, perinatal mortality, cesarean section, placenta previa, placental abruption, preeclampsia, and birth defects. These key factors are expected to restrain the growth of the market over the forecast period.  

MARKET GROWTH CHALLENGES

The ongoing pandemic situation has hampered the growth of the market to a significant extent, which has created a major challenge for the market’s growth. Also, the high cost of the assisted reproductive technology (ART) procedure and the associated risk with IVF treatment are expected to limit market growth over the forecast period. Also, a lack of awareness regarding the procedures is expected to be a major hamper for the market’s growth over the forecast the period. 

CUMULATIVE GROWTH ANALYSIS

The report provides an in-depth analysis of global Assisted Reproductive Technology market, including market size, and compound annual growth rate (CAGR) for the forecast period of 2022-2028, considering 2021 as the base year. The increasing demand for Assisted Reproductive Technology in reproductive healthcare applications has led to the increasing demand for the market and is expected to witness the growth at a specific CAGR from 2021-2028.

11474-assisted-reproductive-technology-market-report

ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTAL OVERVIEW

The global Assisted Reproductive Technology market comprises of different market segments like type, product, end users, and geography. 

ASSISTED REPRODUCTIVE TECHNOLOGY MARKET BY TYPE 

By type, the Assisted Reproductive Technology market includes the key segments of 

  • In-Vitro Fertilization (IVF)
  • Artificial Insemination
  • Surrogacy
  • Others

The in-vitro fertilization (IVF) segment is further segmented into fresh donor, frozen donor, fresh non-donor and frozen non-donor. The artificial insemination segment is further segmented into intrauterine insemination, intracervical insemination, intravaginal insemination, and intratubal insemination. The IVF segment is expected to lead the market over the forecast period. The frozen non-donor sub-segment is expected to account for a significant portion of revenue over the projected time period. This growth is due to the benefits associated with frozen non-donors compared to other IVF procedures. The donor-free frozen procedure is used when the woman releases healthy eggs and undergoes an assisted reproductive technology procedure due to male infertility or tubal malformation.

The artificial insemination segment is expected to register the fastest CAGR during the forecast period. Artificial insemination is intended for minor fertility problems and is usually performed for same-sex couples or single women. The success rate of artificial insemination varies with age. According to the Human Fertilization and Embryology Authority (HFEA), the success rate of artificial insemination per individual cycle is approximately 15.8% for women under the age of 35, 11% for women aged 35 to 39 years, and 4.7% for women aged 40 to 42 years. In addition, more than 50% of women undergoing intrauterine insemination will have a child during the first 6 cycles.

ASSISTED REPRODUCTIVE TECHNOLOGY MARKET BY PRODUCT

By product, the Assisted Reproductive Technology market is segmented into 

  • Instruments
  • Reagents and Media
  • Accessories and Disposables

The instruments segment is further segmented into sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, cabinet, micromanipulator, laser systems, and others. The reagents and media segment is further segmented into cryopreservation media, semen processing media, ovum processing media and embryo culture media. The accessories and disposables segment is expected to dominate the market over the forecast period as the prevalence of infertility increases, demand for in vitro fertilization procedures such as ova, sperm analysis, and screening increases, gamete management and others. 

However, the reagents and media segment is expected to experience significant market growth over the forecast period as the demand for frozen embryo transfers increases, the prevalence of infertility rises, and the number of in-vitro fertilization procedures also increases globally.

ASSISTED REPRODUCTIVE TECHNOLOGY MARKET BY END USERS

The Assisted Reproductive Technology market has major end users like 

  • Hospitals and Clinics
  • Fertility Clinics
  • Surgical Centers
  • Clinical Research Institutes
  • Others

The fertility clinics segment is expected to maintain its lead position in the market during the forecast period. The high proportion and rapid growth are due to an increasing number of infertility cases and the need for a specialized site to perform assisted reproductive technology procedures.

The hospitals and clinics segment in low-and middle-income countries is expected to grow lucratively due to insufficient infrastructure to set up fertility clinics; Therefore, multi-specialty hospitals have become the most accessible option for infertility treatment.

ASSISTED REPRODUCTIVE TECHNOLOGY MARKET BY GEOGRAPHY

The global Assisted Reproductive Technology market is studied for the following regions 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the world (RoW)

The European region is expected to grow at the highest rate in the market over the forecast period. The high growth can be attributed to an increase in infertility rates, increased awareness of fertility treatments, advances in technology and supportive government initiatives. For example, according to the European Society of Human Reproduction and Embryology, about 25 million people in the European Union suffer from infertility, which is the highest in the world. 

Significant growth is expected for North America during the forecast period. The growth is attributed to the positive outcomes of patients undergoing the treatment. According to the CDC, 2.1% of infants in the United States are born via assisted reproductive technology, and among them, 5.5% of infants are born in Massachusetts, which is the highest, followed by 5.0% in the District of Columbia and 4.4% in New Jersey. 

Asia-Pacific is expected to grow at a high rate over the forecast period. Advancements in technology and growing research for assisted reproductive technology are expected to drive the growth of the Asia-Pacific region. According to the article published in the Reproductive Medicine and Biology Journal, around 458,101 assisted reproductive technology cycles were performed in Japan in 2019, with around 60,598 newborns born. In 2019, there were about 624 registered establishments for assisted reproductive technology in Japan, and 598 establishments reported some form of assisted reproductive technology treatment.

COVID-19 IMPACT ANALYSIS ON GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET

Axiom MRC provides a 360-degree analysis of micro and macro-economic factors on the global Assisted Reproductive Technology market. In addition, an complete analysis of changes in the global Assisted Reproductive Technology market expenditure, economic and international policies on supply and demand side is included in this exclusive report. The report also studies the impact of the pandemic on global economies, international trade, business investments, GDP, and marketing strategies of key players present in the market. 

The pandemic has had a negative impact on the sector due to the cessation of activities and the consequent reduction in the volumes of patient care. According to Sympathy Health's Data-Assisted Reproductive Technology Study, including data from 280 million US individuals, a significant decrease in assisted reproductive technology procedures was reported in March-April 2020 compared to 2019 due to fears of COVID-infection. The industry has tried to quickly recover to pre-pandemic numbers due to the resumption of advice and treatment by the American Society for Reproductive Medicine, the European Society for Human Reproduction and Embryology (ESHRE), and the International Federation of fertility societies. Also, the technological advancements and the adoption of telemedicine in the field of assisted reproductive technology are expected to drive the growth of the industry in the post-pandemic phase.

COMPETITIVE LANDSCAPE ANALYSIS

The competitive landscape analysis of Assisted Reproductive Technology market is majorly focused on expanding the global growth of assisted reproductive technology with new product innovation, business expansion, and the increasing presence of a range of manufacturers operating in the assisted reproductive technology market has led to the growing demand for the market.  Besides, the market offers a range of products in different applications to fulfil the requirements of consumers, which is further contributing to healthy growth in the market.  

The key players studied in market are 

  • CooperSurgical, Inc.
  • Cosmos Biomedical Ltd.
  • Microm U.K. Ltd.
  • California Cryobank
  • Bloom IVF Centre
  • Parallabs
  • Genea Biomedx
  • Fujifilm Holdings Corporation
  • OvaScience
  • Anecova
  • Origio
  • Microm Ltd.
  • Merck KGaA
  • Ferring Pharmaceuticals
  • Thermo Fisher Scientific, Inc. 
  • Millendo Therapeutics, Inc.
  • Oxford Gene Technology
  • Progyny Inc.


RECENT DEVELOPMENT:

July 2021: Hamilton Throne Ltd., a provider of assisted reproductive technology research has acquired IVFTECH ApS (IVFtech) and its associated firm, K4 Technology ApS. IVFtech is dedicated to providing laminar flow workstations and huge-capacity incubators for the ART with the aid of its associated firm, K4. The transaction was worth USD 8 million.

January 2021: CooperSurgical has acquired Embryo Options, a provider of cryo-storage software solutions for fertility clinics. Embryo Options platform had intended to aid the patients by giving access to its online resources to provide knowledge about stored specimens for future assisted reproductive technology treatment cycles. 

ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SUMMARY

By type, the Assisted Reproductive Technology market includes the key segments of in-vitro fertilization (IVF), artificial insemination, surrogacy, and others. The in-vitro fertilization (IVF) segment is further segmented into fresh donor, frozen donor, fresh non-donor, and frozen non-donor. The artificial insemination segment is further segmented into intrauterine insemination, intracervical insemination, intravaginal insemination, and intratubal insemination. The IVF segment is expected to lead the market over the forecast period. By product, the Assisted Reproductive Technology market is segmented into instruments, reagents, media, accessories, and disposables. The instruments segment is further segmented into sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, cabinet, micromanipulator, laser systems and others. The reagents and media segment is further segmented into cryopreservation media, semen processing media, ovum processing media and embryo culture media. The accessories and disposables segment is expected to dominate the market over the forecast period as the prevalence of infertility increases, demand for in vitro fertilization procedures such as ova, sperm analysis and screening increases, gamete management and others. The Assisted Reproductive Technology market has major end users like hospitals and clinics, fertility clinics, surgical centers, clinical research institutes and others. The fertility clinics segment is expected to maintain its lead position in the market during the forecast period. The global Assisted Reproductive Technology market is studied for the following regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). The European region is expected to grow at the highest rate in the market over the forecast period.

SCOPE OF THE REPORT:

Market Sizing for Year:
2019-2028
Base Year:
2021
Forecast Period:
2022-2028
Value:
USD million
Market Segment studied:

Type

Product

End Users

Geography
Market Players and its Competitors:

CooperSurgical, Inc.

Cosmos Biomedical Ltd.

Microm U.K. Ltd.

California Cryobank

Bloom IVF Centre

Parallabs

Genea Biomedx

Fujifilm Holdings Corporation

OvaScience

Anecova

Origio

Microm Ltd.

Merck KGaA

Ferring Pharmaceuticals

Thermo Fisher Scientific, Inc. 

Millendo Therapeutics, Inc.

Oxford Gene Technology

Progyny Inc.

FREQUENTLY ASKED QUESTIONS

What would be forecast period in the market report?

2022-2088 is the forecast period in the market report

What are the drivers for Assisted Reproductive Technology market?

The key driving factors of the market are increasing prevalence of infertility, rising disposable income and rise in awareness regarding infertility treatment.

Which region is gaining majority of market share during the forecast period (2022-2028)?

Europe region is expected to gain major market share during the forecast period (2022-2028).